Clinical trial

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

NCT01309022

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Study timeline

Registry last updated2016-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

SirolimusDRUG · verified · RxNorm: sirolimus

TacrolimusDRUG · verified · RxNorm: tacrolimus

Mycophenolate mofetilDRUG · verified · RxNorm: mycophenolate mofetil

Mycophenolic acidDRUG · verified · RxNorm: mycophenolic acid

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Immune Tolerance Network (ITN)collaborator

Mapped research locations

BostonMassachusetts, United States1 St LouisMissouri, United States1 MiamiFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01309022 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.